- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Marksans Pharma Limited — Updates, 19-11-2025: Press Release
19-11-2025 | 11:23 am
19-11-2025 | 11:23 am
Marksans Pharma's subsidiary secured US market entry for Loperamide Hydrochloride Tablets (OTC), an anti-diarrheal drug. This expands their product offerings and boosts potential revenue streams in the over-the-counter segment.
No comments yet. Be the first to comment!